Answer
Nuromol Dual Action is contraindicated in the third trimester because prostaglandin inhibition may cause fetal cardiopulmonary toxicity (premature ductus arteriosus constriction/closure and pulmonary hypertension), renal dysfunction, prolonged bleeding in mother and newborn, and inhibited uterine contractions causing delayed or prolonged labour.
Sources for this answer
- Nuromol Dual Action Pain Relief 200mg/500mg tabletsReckitt Benckiser Healthcare (UK) Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked